3rd March 2026
One under-discussed shift in 2026: While parts of the labour market feel tight, executive-level movement is staying active — and AI-fluent leadership is showing up more often in the shortlist.
Industry commentary this month points to a rise in C-suite roles and the reality that many senior hires are still filled through direct outreach and private networks, not job boards. (The Times)
What this means for senior search in biopharma:
Your “visible” candidate pool is not the real pool
Narrative + credibility in AI-enabled delivery matters more than buzzwords on profiles.
Shortlists need people who can connect AI to measurable outcomes and regulated execution.
This is exactly where many searches stall: the market is full of AI talk — but scarce in leaders who can operationalise it.
hashtagHeadhunting hashtagLifeSciencesLeadership hashtagBiotech hashtagPharma hashtagAILeadership
